A carregar...

Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults.

In a randomized, double-blind trial involving patients with uncomplicated influenza A H3N2 subtype virus infection, rimantadine treatment (200 mg/day for 5 days) was associated with significant reductions in nasal secretion viral titers (days 2 through 4), maximal temperature (days 2 and 3), time un...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hayden, F G, Monto, A S
Formato: Artigo
Idioma:Inglês
Publicado em: 1986
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC176405/
https://ncbi.nlm.nih.gov/pubmed/3521480
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!